# Phio Pharmaceuticals Corp.: Form 8-K, filed Mar 26, 2020

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2020-03-26
- Accepted by EDGAR: Mar 26, 2020, 17:26 ET
- Period: 2020-03-26
- Accession: 0001683168-20-000971
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316820000971/phio_8k-032620.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316820000971/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316820000971/phio_8k-032620.htm

Filed Mar 26, 2020.
Source: SEC EDGAR, the filing index for accession 0001683168-20-000971. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
